239 related articles for article (PubMed ID: 7875490)
1. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Ramage JK; Donaghy A; Farrant JM; Iorns R; Williams R
Gastroenterology; 1995 Mar; 108(3):865-9. PubMed ID: 7875490
[TBL] [Abstract][Full Text] [Related]
2. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
Hultcrantz R; Olsson R; Danielsson A; Järnerot G; Lööf L; Ryden BO; Wahren B; Broomé U
J Hepatol; 1999 Apr; 30(4):669-73. PubMed ID: 10207809
[TBL] [Abstract][Full Text] [Related]
3. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
Siqueira E; Schoen RE; Silverman W; Martin J; Rabinovitz M; Weissfeld JL; Abu-Elmaagd K; Madariaga JR; Slivka A
Gastrointest Endosc; 2002 Jul; 56(1):40-7. PubMed ID: 12085033
[TBL] [Abstract][Full Text] [Related]
4. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
5. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis.
Björnsson E; Kilander A; Olsson R
Liver; 1999 Dec; 19(6):501-8. PubMed ID: 10661684
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis.
Nichols JC; Gores GJ; LaRusso NF; Wiesner RH; Nagorney DM; Ritts RE
Mayo Clin Proc; 1993 Sep; 68(9):874-9. PubMed ID: 8396700
[TBL] [Abstract][Full Text] [Related]
7. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis.
Wannhoff A; Rupp C; Friedrich K; Knierim J; Flechtenmacher C; Weiss KH; Stremmel W; Gotthardt DN
Dig Dis Sci; 2017 Feb; 62(2):510-516. PubMed ID: 27943017
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis.
Lindberg B; Arnelo U; Bergquist A; Thörne A; Hjerpe A; Granqvist S; Hansson LO; Tribukait B; Persson B; Broomé U
Endoscopy; 2002 Nov; 34(11):909-16. PubMed ID: 12430077
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
12. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
[TBL] [Abstract][Full Text] [Related]
13. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
Charatcharoenwitthaya P; Enders FB; Halling KC; Lindor KD
Hepatology; 2008 Oct; 48(4):1106-17. PubMed ID: 18785620
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
[TBL] [Abstract][Full Text] [Related]
15. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.
Fisher A; Theise ND; Min A; Mor E; Emre S; Pearl A; Schwartz ME; Miller CM; Sheiner PA
Liver Transpl Surg; 1995 Mar; 1(2):94-8. PubMed ID: 9346547
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review.
Walker SL; McCormick PA
Abdom Imaging; 2008; 33(1):14-7. PubMed ID: 17874262
[TBL] [Abstract][Full Text] [Related]
17. Early detection and treatment of cholangiocarcinoma.
Gores GJ
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S30-4. PubMed ID: 11084082
[TBL] [Abstract][Full Text] [Related]
18. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
19. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
[TBL] [Abstract][Full Text] [Related]
20. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
